Table 1.
Distribution of Clinicopathological Features, Sites of the Lesion, and Subtypes of T and NK Cell Lymphoma Patients (n = 32).
| Variables | Mean (SD) | n (%) |
|---|---|---|
| Age | 38.2 (22.7) | |
| Age group | ||
| Less than 60 | 24 (75.0) | |
| More than 60 | 8 (25.0) | |
| Race | ||
| Malay | 29 (90.6) | |
| Chinese | 2 (6.3) | |
| Indian | 1 (3.1) | |
| Gender | ||
| Male | 21 (65.6) | |
| Female | 11 (34.4) | |
| Site | ||
| Nodal | 10 (31.3) | |
| Extra nodal | 22 (68.8) | |
| Extra nodal | ||
| Less than 1 | 25 (78.1) | |
| More than 1 | 7 (21.9) | |
| Ann-Arbor staging | ||
| I-II | 16 (50.0) | |
| III-IV | 16 (50.0) | |
| LDH value | ||
| Normal | 14 (43.8) | |
| Elevated | 18 (56.3) | |
| ECOG | ||
| Less than 2 | 15 (46.9) | |
| More than 2 | 17 (53.1) | |
| B symptoms | ||
| Yes | 12 (37.5) | |
| No | 20 (62.5) | |
| IPI score | ||
| 0 to 2 | 18 (56.3) | |
| 3 to 5 | 14 (43.8) | |
| Sites of lesion | ||
| Nodal | 10 (31.3) | |
| Extranodal | 22 (68.7) | |
| Bone | 4 (12.5) | |
| Nasopharynx | 6 (18.8) | |
| Skin | 3 (9.4) | |
| Soft tissue | 3 (9.4) | |
| Tonsils | 2 (6.3) | |
| Trephine | 4 (12.5) | |
| Subtypes | ||
| ALK-not done, ALCL | 1 (3.1) | |
| ALK-negative, ALCL | 1 (3.1) | |
| ALK-positive, ALCL | 6 (18.8) | |
| AITL | 1 (3.1) | |
| ENTKL, nasal type | 3 (9.4) | |
| PTCL, NOS | 6 (18.8) | |
| Variables | n (%) | |
| T lymphoblastic lymphoma | 6 (18.8) | |
| T-cell lymphoma (not being subtyped) | 8 (25.0) | |
ALCL, anaplastic large cell lymphoma; ALK, anaplastic lymphoma kinase; AITL, angioimmunoblastic T cell lymphoma; ENTKL, extranodal T and NK cell lymphoma; PTCL, peripheral T cell lymphoma; NOS, not otherwise specified.